GlassScriptPhysician profile
Timothy D Hodges
NPI 1881618999
$8,850.85
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,815 · 2020: $1,151 · 2021: $5,583 · 2022: $82.02 · 2023: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $5,614.64 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $439.17 | 2019-2020 | |
| Glaxosmithkline, LLC. | $392.84 | 2019-2023 | Shingrix |
| Novo Nordisk INC | $384.47 | 2019-2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $260.59 | 2019-2020 | |
| Amgen INC. | $232.77 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $193.03 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $182.48 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $181.72 | 2019-2020 | |
| Abbvie INC. | $152.12 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $120.04 | 2019-2020 | |
| Pfizer INC. | $107.29 | 2019-2023 | |
| Antares Pharma, INC. | $92.54 | 2019-2023 | Nocdurna, Tlando, Xyosted |
| Astellas Pharma US INC | $72.07 | 2019-2020 | |
| Amarin Pharma, INC. | $70.20 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $64.16 | 2019-2020 | |
| Nalpropion Pharmaceuticals LLC | $61.32 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $61.04 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $42.55 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $35.96 | 2019 | |
| Currax Pharmaceuticals LLC | $24.05 | 2020 | |
| Shire North American Group INC | $21.00 | 2019 | |
| Exact Sciences Corporation | $19.74 | 2023 | Cologuard Collection Kit |
| Ironshore Pharmaceuticals INC. | $13.54 | 2019 | |
| Allergan, INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Hodges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.